Marjolijn van Keep

Varying Willingness to Pay Based on Severity of Illness: Impact on Health Technology Assessment Outcomes of Inpatient and Outpatient Drug Therapies in The Netherlands

Marieke Schurer, Suzette M. Matthijsse, Carla Y. Vossen et al. · Value in Health · 2021 · 40 citations

Pharmacy, Health Policy, Pharmacoeconomics +17

Is Adding HCV Screening to the Antenatal National Screening Program in Amsterdam, The Netherlands, Cost-Effective?

Anouk T. Urbanus, Marjolijn van Keep, Amy Matser et al. · PLoS ONE · 2013 · 26 citations · Full text

Pharmacy, Health Sciences, Maternal Health +17

Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK

Paul Emery, Marjolijn van Keep, Steve Beard et al. · PharmacoEconomics · 2018 · 25 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Cost-Effectiveness of Durvalumab After Chemoradiotherapy in Unresectable Stage III NSCLC: A US Healthcare Perspective

Ranee Mehra, Candice Yong, Brian Seal et al. · Journal of the National Comprehensive Cancer Network · 2021 · 19 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17